Clicky

Werewolf Therapeutics, Inc.(HOWL) News

Date Title
Oct 4 Werewolf Therapeutics to Present Posters at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting
Jun 25 Werewolf Therapeutics Highlights Initial Safety and Efficacy Data from its Ongoing Phase 1 Clinical Trial Evaluating WTX-330 in Patients with Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphoma
May 3 Werewolf Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
Apr 24 Werewolf Therapeutics Announces WTX-124 Clinical Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Apr 23 Werewolf Therapeutics Presents First Preclinical Data Highlighting IL-10 INDUKINE Molecules as a Potential Therapy for Inflammatory Bowel Disease (IBD) at AAI Annual Meeting
Apr 15 All You Need to Know About Werewolf Therapeutics (HOWL) Rating Upgrade to Buy
Apr 5 Werewolf Therapeutics Presents Preclinical Results Demonstrating Anti-Tumor Effects of Pro-Inflammatory Cytokine Therapeutics WTX-518 and WTX-712 at AACR 2024 Annual Meeting
Apr 4 Werewolf Therapeutics to Present First-of-Its-Kind Data Demonstrating Utility for PREDATOR™ Platform in Immunology-Based Diseases at AAI Annual Meeting
Mar 12 How Much Upside is Left in Werewolf Therapeutics, Inc. (HOWL)? Wall Street Analysts Think 92.37%
Mar 9 Werewolf Therapeutics Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
Mar 7 Werewolf Therapeutics, Inc. (HOWL) Reports Q4 Loss, Lags Revenue Estimates
Mar 7 Werewolf Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Mar 6 Werewolf Therapeutics to Present at the 2024 Leerink Partners Global Biopharma Conference
Mar 5 Werewolf Therapeutics Announces Upcoming Presentations at AACR Annual Meeting 2024
Dec 14 Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Stock Catapults 26% Though Its Price And Business Still Lag The Industry
Dec 7 Institutions profited after Werewolf Therapeutics, Inc.'s (NASDAQ:HOWL) market cap rose US$14m last week but private equity firms profited the most
Aug 24 Nvidia upgraded, Estee Lauder downgraded: Wall Street's top analyst calls